292 related articles for article (PubMed ID: 1457952)
21. Increasing dialysate flow rate increases dialyzer urea mass transfer-area coefficients during clinical use.
Ouseph R; Ward RA
Am J Kidney Dis; 2001 Feb; 37(2):316-20. PubMed ID: 11157372
[TBL] [Abstract][Full Text] [Related]
22. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
23. Middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
Eloot S; de Vos JY; de Vos F; Hombrouckx R; Verdonck P
Hemodial Int; 2005 Oct; 9(4):399-408. PubMed ID: 16219061
[TBL] [Abstract][Full Text] [Related]
24. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
[TBL] [Abstract][Full Text] [Related]
25. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
Ouseph R; Hutchison CA; Ward RA
Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
[TBL] [Abstract][Full Text] [Related]
26. Disordered breathing patterns during bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone membranes.
Navarro J; Serrano C; Donna E; Perez GO
ASAIO J; 1992; 38(4):811-4. PubMed ID: 1450477
[TBL] [Abstract][Full Text] [Related]
27. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
McCarthy JT; Jenson BM; Squillace DP; Williams AW
Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
[TBL] [Abstract][Full Text] [Related]
28. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
Joy MS; Matzke GR; Frye RF; Palevsky PM
Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
[TBL] [Abstract][Full Text] [Related]
29. Dialysate and blood flow dependence of diffusive solute clearance during CVVHD.
Relton S; Greenberg A; Palevsky PM
ASAIO J; 1992; 38(3):M691-6. PubMed ID: 1457951
[TBL] [Abstract][Full Text] [Related]
30. Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers.
Murthy BV; Sundaram S; Jaber BL; Perrella C; Meyer KB; Pereira BJ
J Am Soc Nephrol; 1998 Mar; 9(3):464-72. PubMed ID: 9513910
[TBL] [Abstract][Full Text] [Related]
31. Impact of blood and dialysate flow and surface on performance of new polysulfone hemodialysis dialyzers.
Mandolfo S; Malberti F; Imbasciati E; Cogliati P; Gauly A
Int J Artif Organs; 2003 Feb; 26(2):113-20. PubMed ID: 12653344
[TBL] [Abstract][Full Text] [Related]
32. Clearance of levofloxacin by an in vitro model of continuous venovenous hemodialysis (CVVHD).
Siewert S; Drewelow B; Mueller SC
Int J Artif Organs; 2007 Oct; 30(10):889-95. PubMed ID: 17992649
[TBL] [Abstract][Full Text] [Related]
33. Effects of a reduced inner diameter of hollow fibers in hemodialyzers.
Ronco C; Brendolan A; Lupi A; Metry G; Levin NW
Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106
[TBL] [Abstract][Full Text] [Related]
34. Comparison of urea clearance in low-efficiency low-flux vs. high-efficiency high-flux dialyzer membrane with reduced blood and dialysate flow: an in vitro analysis.
Munshi R; Ahmad S
Hemodial Int; 2014 Jan; 18(1):172-4. PubMed ID: 23714225
[TBL] [Abstract][Full Text] [Related]
35. Solute transport in continuous hemodialysis: a new treatment for acute renal failure.
Sigler MH; Teehan BP
Kidney Int; 1987 Oct; 32(4):562-71. PubMed ID: 3430952
[TBL] [Abstract][Full Text] [Related]
36. Extended reuse of polysulfone hemodialysis membranes using citric acid and heat.
Tonelli M; Dymond C; Gourishankar S; Jindal KK
ASAIO J; 2004; 50(1):98-101. PubMed ID: 14763499
[TBL] [Abstract][Full Text] [Related]
37. Continuous venovenous hemodialysis in multiple organ systems failure patients with acute renal failure.
Fang JT; Chen YC; Tien YC; Huang CC
Changgeng Yi Xue Za Zhi; 1998 Jun; 21(2):146-51. PubMed ID: 9729647
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of dialyzer jacket structure and hollow-fiber dialysis membranes to achieve high dialysis performance.
Hirano A; Yamamoto K; Matsuda M; Ogawa T; Yakushiji T; Miyasaka T; Sakai K
Ther Apher Dial; 2011 Feb; 15(1):66-74. PubMed ID: 21272255
[TBL] [Abstract][Full Text] [Related]
39. Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis.
Abe M; Okada K; Ikeda K; Matsumoto S; Soma M; Matsumoto K
Artif Organs; 2011 Apr; 35(4):398-403. PubMed ID: 21314833
[TBL] [Abstract][Full Text] [Related]
40. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.
Lorenzin A; Garzotto F; Alghisi A; Neri M; Galeano D; Aresu S; Pani A; Vidal E; Ricci Z; Murer L; Goldstein SL; Ronco C
Pediatr Nephrol; 2016 Oct; 31(10):1659-65. PubMed ID: 27139897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
